Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
alleviate, ANDA, bridging, budget, concurrent, conventional, coordination, disciplined, faster, FDIC, fourth, hand, immaterial, ineffective, invoice, justified, Los, path, receivership, repetition, replenish, safer, Silicon, slight, superseded, SVB, tranche, unchanged, unconstitutional, unemployment, UNRESOLVED, Valley
Filing tables
Filing exhibits
Related press release
RVPH similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-254551) and the Registration Statements on Form S-3 (File Nos. 333-262348, 333-251802 and 333-255323), of our report dated March 30, 2023 relating to the consolidated financial statements of Reviva Pharmaceuticals Holdings, Inc. which appears in this Form 10-K for the year ended December 31, 2022.
/s/ Armanino LLP | |
San Ramon, California |
March 30, 2023